A wrong diagnosis does not merely waste the cost of one solution; it can quietly determine where the organisation wastes money for years.

When performance deteriorates, leadership teams understandably want action.

Revenue misses expectations. Costs rise. Customer complaints increase. A transformation slips. Productivity falls.

The problem is named.

A response follows.

Perhaps technology needs replacing. Perhaps the operating model is wrong. Perhaps another management layer should disappear. Perhaps capability needs strengthening.

Budgets are approved. People are mobilised. Consultants arrive. Progress is reported.

And sometimes things improve.

That is where the real danger can begin.

Improvement is not proof that the diagnosis was correct

Most organisational problems have multiple contributing factors. Changing almost anything significant can temporarily alter performance.

A restructure can create renewed attention.

New technology can remove obvious friction.

A cost programme can improve the numbers.

A new executive can inject energy and accountability.

The organisation sees improvement and concludes:

We were right about the problem.

But the real test comes later.

If the underlying conditions that generated the problem remain unchanged, the symptoms eventually return.

Perhaps in six months.

Perhaps in two years.

Perhaps somewhere else in the organisation.

Now leadership faces what appears to be another problem.

And the meter starts running again.

The second solution costs more than the first

Financially, recurrence is relatively easy to see.

Another programme budget.

Another advisory engagement.

Another technology investment.

Another round of redundancies.

Another transformation.

But those numbers capture only part of the cost.

The organisation has already consumed management attention, employee capacity and time that could have been invested elsewhere.

When the problem returns, those costs are incurred again.

Then something more damaging happens.

The organisation begins paying interest on the original misdiagnosis.

People remember the previous promises.

“We fixed this.”

“This operating model will solve it.”

“This transformation will address the root causes.”

“This time will be different.”

When those promises prove temporary, the next initiative begins with less organisational confidence than the previous one.

Misdiagnosis compounds through people

Imagine leadership announces another transformation addressing a problem employees have watched the organisation attempt to solve three times before.

What happens?

People may comply.

But compliance is not belief.

They become slower to commit emotionally. Experienced employees quietly hedge their bets. Managers become cautious about making promises. Employees wait to see whether this initiative survives longer than the last one.

The organisation may call this change resistance.

But sometimes it is organisational learning.

People have learned that yesterday's permanent solution can become tomorrow's abandoned initiative.

The cost of misdiagnosis has now moved beyond the P&L.

It has entered organisational behaviour.

Eventually, credibility becomes part of the bill

This is where repeated misdiagnosis becomes particularly dangerous for CEOs and boards.

Every major intervention carries an implicit leadership claim:

We understand sufficiently what is happening to justify this action.

When interventions repeatedly fail to produce durable results, confidence in that claim weakens.

Employees become cynical.

Executives become defensive.

Boards become impatient.

Risk appetite contracts because another failed initiative feels increasingly difficult to justify.

Leadership turnover may follow, creating yet another reset.

New executives arrive with new interpretations. Strategies change. Priorities shift. Another programme begins.

The organisation can spend enormous amounts of money while appearing constantly active and yet make surprisingly little lasting progress.

This is Karamawari

The Japanese word 空回り (karamawari) describes effort that produces motion without corresponding progress.

It is a useful metaphor for organisations trapped in repeated misdiagnosis.

The individual solutions may be perfectly reasonable.

The technology may work.

The consultants may be capable.

The restructure may be executed well.

The transformation may hit its milestones.

But technically sound solutions cannot permanently solve a problem they have misunderstood.

If leadership keeps interpreting the recurring problem through essentially the same frame, every subsequent response inherits the weakness of that frame.

The organisation does not merely repeat the solution.

It repeats the thinking that selected it.

The economics should change the question

When another recurring problem reaches the executive table, the natural question is:

“How much will it cost to fix?”

That question matters.

But there is a financially more important one:

“What will it cost if our diagnosis is wrong?”

Consider not only the proposed investment, but the downside of another cycle.

The capital consumed.

The management capacity diverted.

The opportunity cost.

The employee fatigue.

The delayed strategy.

The loss of credibility.

And perhaps most importantly, another year in which the underlying problem continues quietly generating consequences.

For a problem that has already survived several serious attempts to solve it, spending more on another solution without increasing confidence in the diagnosis may be the greatest risk of all.

Before funding another fix, challenge the frame

Recurring problems deserve a different standard of scrutiny.

If capable people have already tried reasonable solutions and the problem keeps returning, perhaps the organisation does not have a solution problem.

Perhaps it has a diagnosis problem.

That distinction should matter enormously to CEOs and boards.

Because the cost of the next initiative appears in its business case.

The cost of being wrong again rarely does.

So before approving another system, restructure, transformation or turnaround, perhaps the most commercially important question is this:

How much capital, capacity and leadership credibility are you prepared to compound before questioning whether the problem you keep solving is actually the problem you have?